INVESTOR REACTION TO THE ANNOUNCEMENT OF FIRST COVID-19 VACCINATION IN INDONESIA
Article Sidebar
Main Article Content
Abstract
The COVID-19 pandemic has had a huge impact around the world and presents unprecedented challenges to the health sector. Vaccination programme is a solution to suppress the spread of COVID-19. The purpose was to explain the reaction of the capital market to the announcement of the first COVID-19 vaccination in Indonesia by focusing the differences in abnormal return and trading volume activity before and after the event of vaccination programme. The research method used is quantitative method by secondary data analysis with event study. The event date in this research was January 13rd, 2021 when Indonesia began its nationwide COVID-19 vaccination programme. This event study took a sample of 17 companies in healthcare sector listed on Indonesia Stock Exchange. The event period used was 14 days, 7 days before and 7 days after the announcement of the first COVID-19 vaccination in Indonesia. This research uses descriptive statistical techniques, normality test (one-sample kolmogorov-smirnov test), and paired sample t-test. The results of the paired sample t-test show that there is a significant difference between the abnormal return before and after the announcement of the first COVID-19 vaccination in Indonesia. However, there is no significant difference of trading volume before and after the announcement of the first COVID-19 vaccination in Indonesia.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
IJAEB by Graduate Program of Universitas Tarumanagara is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.. Permissions beyond the scope of this license may be available at https://journal.untar.ac.id/index.php/ijaeb
References
Agrivina, D. & Komara, E. F. (2022). Analisis abnormal return, trading volume activity, dan market capitalization sebelum dan sesudah vaksinasi COVID-19 pada sektor infrastuktur. SAINS: Jurnal Manajemen dan Bisnis, 15, 1-14.
Ayudiastuti, L (2021). Analisa pengaruh keputusan investasi mahasiswa. Jurnal Ilmu Manajemen, 9, 1138-1149.
Dian Erika Nugraheny, D. E. & Icha Rastika, Dimulainya vaksinasi COVID-19 di Indonesia, Kompas, Jakarta, 2021.
Fadhilah, R. I. & Yunita, I. (2021). Analisis reaksi pasar modal terhadap peristiwa pengumuman awal vaksin sinovac masuk ke Indonesia. E-Proceeding of Management, 8, 4358-4366.
Fajarwati, P. Y. & Nurasik (2020). Capital market reaction analysis before and after bank Indonesia's decision regarding interest rates. Academia Open, 3, 1-14.
Ibrahim, A. & Lasmanah (2022). Analisis perbandingan abnormal Return dan trading volume activity sebelum dan sesudah dilakukannya vaksinasi COVID-19 di Indonesia. Bandung Conference Series: Business and Management, 2, 396-403.
Kinasih, H. W. & Laduny, M. F. (2022). Analisis komparatif abnormal return, cumulative abnormal return dan trading volume activity: event study kedatangan vaksin sinovac. Ekuivalensi: Jurnal Ekonomi Bisnis, 7, 84-98.
Peraturan Menteri Kesehatan (Permenkes) Nomor 84 Tahun 2020. Peraturan menteri kesehatan nomor 84 tahun 2020 tentang pelaksanaan vaksinasi dalam rangka penanggulangan pandemi corona virus disease 2019.
Purnami, N. K. S. & Devi, S. (2022). Reaksi pasar modal terkait penyuntikan vaksin COVID 19 pertama Indonesia pada perusahaan sektor farmasi di Bursa Efek Indonesia. Jurnal Ilmiah Akuntansi dan Humanika, 12, 156-162.
Sahputra, A., Lindrianasari, Dharma, F., & Amelia, Y. (2022). Analisis perbandingan abnormal return dan trading volume activity sebelum dan sesudah diumumkannya kasus pertama COVID-19. Jurnal Akuntansi Bisnis, 15, 29-40.